Achilles Therapeutics PL-ADRACHL
13F holders, Q3 2024 (September 30)22holders −5
4new positions
10sold out
1famous investor
$1.02avg. 13F price*
At the end of Q3 2024, 22 institutions reported holding Achilles Therapeutics PL-ADR (ACHL) in their 13F filings, down 5 from Q2 2024. 4 opened new positions and 10 sold out. The largest holders were Syncona Portfolio Ltd ($11.3M), BML Capital Management, LLC ($4.2M) and FCPM III Services B.V. ($2.4M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Achilles Therapeutics PL-ADR
- CUSIP
- 00449L102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $36K |
| Exits | 10 | $1.7M |
All 13F filers, Q2 2024 → Q3 2024: 3,519,592 shares bought and 2,124,686 shares sold, net +1,394,906 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 22 holders
| Syncona Portfolio Ltd | 14.01% | No change | 11,086,909 | $11.3M |
| BML Capital Management, LLC | 2.46% | Add +555.8% | 4,100,002 | $4.2M |
| FCPM III Services B.V. | 0.42% | No change | 2,390,050 | $2.4M |
| Redmile Group, LLC | 0.10% | No change | 1,608,089 | $1.6M |
| Vestal Point Capital, LP | 0.12% | No change | 1,500,000 | $1.5M |
| Ikarian Capital, LLC | 0.46% | No change | 1,443,181 | $1.5M |
| Siren, L.L.C. | 0.04% | — | 755,375 | $770K |
| Renaissance Technologies | 0.00% | Reduce -6.5% | 638,133 | $651K |
| Boothbay Fund Management, LLC | 0.01% | No change | 420,481 | $429K |
| Acadian Asset Management LLC | 0.00% | No change | 250,825 | $255K |
| Two Sigma Advisers, LP | 0.00% | Reduce -4.7% | 22,400 | $23K |
| Geode Capital Management, LLC | 0.00% | No change | 21,590 | $22K |
| Two Sigma Investments, LP | 0.00% | Reduce -1.1% | 21,249 | $22K |
| Corsair Capital Management, L.P. | 0.00% | New | 20,000 | $20K |
| Morgan Stanley | 0.00% | Add +84.0% | 16,431 | $17K |
| Susquehanna International Group, LLP | 0.00% | New | 12,434 | $13K |
| Baader Bank Aktiengesellschaft | 0.00% | Add +14.7% | 14,184 | $10K |
| Brave Asset Management Inc. | 0.00% | No change | 10,000 | $10K |
| Rhumbline Advisers | 0.00% | No change | 4,480 | $5K |
| Arcadia Investment Management Corp. | 0.00% | New | 3,000 | $3K |
| JPMorgan Chase & Co. | 0.00% | No change | 137 | $140 |
| Bank of America Corp. | 0.00% | New | 15 | $15 |
"% of holder's portfolio" is ACHL's weight in each manager's 13F, not the share of Achilles Therapeutics PL-ADR the manager owns.